| Top 50 Most Viewed Posts This Week |
|---|
|
Today This Week Last Week This Month Last Month
|
1. My69z: Date: 26-May-2021 Protocol Number: CD15_COVID-19 (1456)  (7) |
| 2. Riztheinvestor: Exactly what you’ve seen for years before many (888) (10) |
| 3. brentie: "“Our understanding of the genetics of cancer, (751) (6) |
| 4. Katangolo: This is extremely intriguing. Thank you. Upon (732) (12) |
| 5. Figgs: I was trying to put a positive spin on massive (703) (2) |
| 6. Riztheinvestor: We have a AI partner with identity under lock and (695) (2) |
| 7. dfwl28: https://youtu.be/GIUu239FWMg (638) (8) |
| 8. Plotinus: You are correct, it is an open label trial. Trial (625) (11) |
| 9. Rosner: Short Interest Report As of Sat, Aug 3, '13 (600) |
| 10. sean007: Here's another mystery...where's the $2 (575) (3) |
| 11. Emmitt: Anyone....My impression from reading some of the (541) (2) |
| 12. My69z: Kat...don't know the legal time limit on tissue & (539) |
| 13. ohm20: FINAL DROP – The One That Makes the Room Go (532) (17) |
| 14. enemyofpluto: 3500 job cuts (by doge, mush and trump) to FDA (529) (17) |
| 15. My69z: 5 in Hiv rolled over in the trial & @ last (526) (2) |
| 16. Evil Rabbit: I'd take a PR around what Dr. J. had for (525) (22) |
| 17. My69z: 3 yrs ago -- ICI Agreement with major institution (513) (8) |
| 18. Katangolo: OK, I’m picking up the jacket and locking the (513) (7) |
| 19. ohm20: Thank you for verifying. Point 2) is an (513) (14) |
| 20. Katangolo: I would sure hope so. That’s how I was reading (504) (3) |
| 21. Riztheinvestor: You are brilliant (494) (1) |
| 22. My69z: 12-07-2020 --- NCT02859961 Enrollment 556 Study (485) (6) |
| 23. My69z: Dr. J brkfst news for u: I had my usual: (484) (1) |
| 24. ohm20: The chemo causes indiscriminate DNA damage across (472) (12) |
| 25. ohm20: Amid the FDA chaos there is a new program that (466) (8) |
| 26. sean007: I'm educated on the same level with AI...as I am (461) (3) |
| 27. Riztheinvestor: Thanks Kat here is what I got. 1. What role does (459) (13) |
| 28. Riztheinvestor: Will AI cut review times? The truth people (459) (6) |
| 29. ohm20: I read it yet again…so this is turning (453) (14) |
| 30. HouseofCards: The fiscal year end was May (451) |
| 31. KenChowder: To be honest, to a layperson like myself, that (450) (13) |
| 32. Katangolo: Gotcha. Sorry I know it was pretty deep and I (449) (9) |
| 33. Katangolo: He’s saying we are onto something Ken. Stay (448) (2) |
| 34. mikeyt1818: That is old, Joel Schoenfeld, former CEO of UNVC (446) (6) |
| 35. KenChowder: Good news, Riz. But what is My saying? Is it that (443) (2) |
| 36. ohm20: the “new MOA” where LL primes cold tumors to (442) (9) |
| 37. KenChowder: The study financed by a mysterious third party (440) (7) |
| 38. 2MartiniGi: "He’s saying we are onto something Ken. Stay (438) (12) |
| 39. ohm20: This is why MARAVIROC Was sidelined. Everyone (438) (9) |
| 40. cardamine: Looks like that 5-year sample deadline is getting (433) (3) |
| 41. MGK_2: just ignore that last post: when is cytodyn's 10k (431) (3) |
| 42. thriftycents: 2025 BIO International Convention I don't think (430) (10) |
| 43. MJS719: And apparently this group of researchers and (428) (6) |
| 44. ohm20: What role does CXCR4 play in this? CXCR4 HIV (427) (9) |
| 45. Rex47: Ironically Dr. Jay was the one who helped Taimed (420) (11) |
| 46. MJS719: Well, at the very least we know that someone at (413) (11) |
| 47. Katangolo: Wow. That’s big. Thanks again for clarifying (412) |
| 48. ohm20: So, is it Leronlimab causes CD4 & CD8 (411) (17) |
| 49. Katangolo: Great stuff, RIZ and MY69Z! This is why MARAVIROC (411) (9) |
| 50. Vintool: By no means do I think I found anything earth (410) (4) |
